APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753UAB2. A total of 12 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DeepCurrents Investment Group LLC | 39,528,000 | $49,938,921 | 2.17% |
LINDEN ADVISORS LP | 15,000,000 | $18,816,676 | 0.19% |
Verition Fund Management LLC | 12,454 | $15,645,338 | 0.18% |
WOLVERINE ASSET MANAGEMENT LLC | 11,766,000 | $14,863,606 | 0.17% |
PALISADE CAPITAL MANAGEMENT, LP | 1,017,000 | $1,284,573 | 0.04% |
LAZARD ASSET MANAGEMENT LLC | 12,242,000 | $15,379 | 0.02% |
KORNITZER CAPITAL MANAGEMENT INC /KS | 300,000 | $371,070 | 0.01% |
D. E. Shaw & Co., Inc. | 5,000,000 | $6,267,238 | 0.01% |
CITIGROUP INC | 504,000 | $623,398 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
JPMORGAN CHASE & CO | 1,195,000 | $1,511,675 | 0.00% |
WELLINGTON MANAGEMENT GROUP LLP | 1,285,000 | $1,591,416 | 0.00% |
This page lists APELLIS PHARMACEUTICALS INC's shareholders in Q3 2023. To view APELLIS PHARMACEUTICALS INC's shareholder history, click here.